Document is current
Any future updates will be listed below
-
Authors
Will, Marie
Liang, Jackson
Metcalfe, Ciara https://orcid.org/0000-0001-7233-661X
Chandarlapaty, Sarat https://orcid.org/0000-0003-4532-8053
- License Information
-
More Information
Article History
Accepted: 29 June 2023
First Online: 27 July 2023
Competing interests
: J.L. and C.M. are both Genentech/Roche employees and own shares of Roche. C.M. is a named co-inventor on patent 11081236 entitled ‘Diagnostic and therapeutic methods for the treatment of breast cancer’. S.C. reports research grants from NIH/NCI and Breast Cancer Research Foundation during the conduct of the study; personal fees from Novartis, AstraZeneca, Nuvalent, Boxer Capital, Effector and Neogenomics; equity/leadership in Totus Medicines and Odyssey Biosciences and grants from Daiichi Sankyo and AstraZeneca outside the submitted work; and a patent for CDK4/CDK6 degraders is also pending. M.W. has no competing interest.
